ArticleBlood2018

USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.

Johanna Melo-Cardenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.